BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Apr 15, 2026; 18(4): 116821
Published online Apr 15, 2026. doi: 10.4251/wjgo.v18.i4.116821
Figure 1
Figure 1 Diagnostic value of chitinase-3-like protein 1 in different liver diseases. A: Receiver operating characteristic (ROC) curve analysis of the diagnostic efficacy of serum chitinase-3-like protein 1 (CHI3L1) for hepatitis; B: ROC curve analysis of the diagnostic efficacy of serum CHI3L1 and the fibrosis-4 index for liver cirrhosis; C: ROC curve analysis of the diagnostic efficacy of serum CHI3L1 for hepatocellular carcinoma (HCC); D: ROC curve analysis of the diagnostic efficacy of serum CHI3L1 for liver cancer recurrence; E: ROC curve analysis of the diagnostic efficacy of serum CHI3L1 on HCC and liver cirrhosis; F: ROC curve analysis of the diagnostic efficacy of serum CHI3L1 and alpha-fetoprotein for HCC. AUC: Area under the receiver operating characteristic curve; CHI3L1: Chitinase-3-like protein 1; FIB-4: Fibrosis-4 index; AFP: Alpha-fetoprotein.